Idexx Laboratories Financial Overview
Idexx Laboratories's market cap is currently $54.98B. The company's EPS TTM is $3.4; its P/E ratio is 54.58; Idexx Laboratories is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $2.93. See an overview of income statement, balance sheet, and cash flow financials.
